Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Invivyd Inc. (NASDAQ-IVVD) shares surged 24.8% on Thursday following an update on the progress of the COVID-19 prevention candidate VYD2311 and the announcement of a new measles antibody discovery.
The company, based in New Haven, Conn., reported that the accumulated COVID-19 cases so far in the ongoing Phase 3 DECLARATION study are sufficient to provide statistically significant support for the highest anticipated efficacy level of VYD2311, even though the trial is only about 50% complete. #GateSquareAprilPostingChallenge #CreatorLeaderboard